Increased norepinephrine levels and decreased dopamine-beta-hydroxylase activity in primary autism.
about
Monoamine oxidase A and A/B knockout mice display autistic-like features.Genes controlling affiliative behavior as candidate genes for autismThe Intense World Theory – A Unifying Theory of the Neurobiology of AutismMonoamines (serotonin and catecholamines) and their derivatives in infantile autism: age-related changes and drug effectsThe pediatric neurotransmitter disordersEnteric bacterial metabolites propionic and butyric acid modulate gene expression, including CREB-dependent catecholaminergic neurotransmission, in PC12 cells--possible relevance to autism spectrum disordersSerum protein profiling and proteomics in autistic spectrum disorder using magnetic bead-assisted mass spectrometry.Effect of propranolol on functional connectivity in autism spectrum disorder--a pilot studyEmerging drugs for the treatment of symptoms associated with autism spectrum disorders.Dopamine beta-hydroxylase gene modulates individuals' empathic abilityUnderstanding and listening to people with autism.MAOA, DBH, and SLC6A4 variants in CHARGE: a case-control study of autism spectrum disorders.Cut-like homeobox 1 and nuclear factor I/B mediate ENGRAILED2 autism spectrum disorder-associated haplotype function.What is regressive autism and why does it occur? Is it the consequence of multi-systemic dysfunction affecting the elimination of heavy metals and the ability to regulate neural temperature?Behavioral and physiological responses to child-directed speech of children with autism spectrum disorders or typical developmentPreserved reward outcome processing in ASD as revealed by event-related potentials.Autism: review of neurochemical investigation.Analysis of transmission of novel polymorphisms in the somatostatin receptor 5 (SSTR5) gene in patients with autism.Pupil and salivary indicators of autonomic dysfunction in autism spectrum disorder.Cortical enlargement in autism is associated with a functional VNTR in the monoamine oxidase A geneThe hyperserotonemia of autism.Plasma beta-endorphin, adrenocorticotropin hormone, and cortisol in autism.Beta-adrenergic antagonism modulates functional connectivity in the default mode network of individuals with and without autism spectrum disorder.Heart rate variability during sleep in children with autism spectrum disorder.Analysis of Copper and Zinc Plasma Concentration and the Efficacy of Zinc Therapy in Individuals with Asperger's Syndrome, Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) and Autism.An aberrant precision account of autism.Plasma dopamine-beta-hydroxylase in childhood psychosis.Overview of selected basic research in autism.Autism and associated behavioral disorders: pharmacotherapeutic intervention.Plasma copper and zinc concentration in individuals with autism correlate with selected symptom severity.Increased Copper in Individuals with Autism Normalizes Post Zinc Therapy More Efficiently in Individuals with Concurrent GI Disease.Larger tonic pupil size in young children with autism spectrum disorder.Genetically determined low maternal serum dopamine beta-hydroxylase levels and the etiology of autism spectrum disorders.Growth hormone response to L-dopa and clonidine in autistic children.Alteration of attentional blink in high functioning autism: a pilot study.Tianeptine: a novel strategy of psychopharmacological treatment of children with autistic disorder.St John's Wort treating patients with autistic disorder.Effects of propranolol on conversational reciprocity in autism spectrum disorder: a pilot, double-blind, single-dose psychopharmacological challenge study.Differing Developmental Trajectories in Heart Rate Responses to Speech Stimuli in Infants at High and Low Risk for Autism Spectrum Disorder.Defense behavior and coping in an autistic savant: the story of Temple Grandin, PhD.
P2860
Q24602037-99CD4448-9E41-4F54-B3AD-6547F897D8DDQ24653976-C66372ED-D711-4DCB-859F-C66FB2B48FDCQ27500386-6BEC4B38-8AE8-447B-A0A7-CF746EE2DD3CQ28188009-CC49BE55-B54A-4A1B-ABA0-A3138041B391Q28240100-073EA822-34A7-4FCD-92DE-1D6DAE321E66Q28542649-EF0824D9-5AE4-4BB0-9169-3F35F6BAF780Q33507115-23A2869A-0968-48A5-8EAD-A48DD5607938Q33895670-F3830E29-2881-4E49-B900-D3949FD1CAC0Q34073325-A5336B14-1370-4720-A993-5C3B66C767D4Q34152424-B5DDCE05-64B5-4CA0-9BF6-0784A8D112D6Q34779087-5E3002F2-6649-4A93-AD4B-CB0914587248Q35151007-F1A67F9F-E404-4118-8847-690D804F8C50Q35817483-67B02022-B409-4F2F-A889-BF40B2572A96Q35999835-DB1D313B-FEE6-4F7F-8990-859240277E30Q36110270-680026DE-2F1D-49C0-8DCC-A32A51874803Q36217611-581134D9-64FF-4C88-BC22-1124C31A5E2BQ36605375-C1110ED4-3B11-4482-ADC8-12482698D8DBQ36795935-B0935C11-8741-43A5-B5E0-3F3A9CC26C79Q37320157-54CD805E-BF47-4AA8-920A-C10BA5DE1BE4Q37364384-D116238C-4CBD-4986-A805-0AB9DE3A67ABQ38004443-B945B6CB-534B-4251-BE12-DCD130D236A5Q39115297-0254DC9B-83AA-496D-9249-A1ED0287D6BAQ39313961-E14FC547-C438-4D79-9CB2-8F72616ADD1FQ39524291-E90E9E45-4994-4D95-BE74-4C7D10AE2BBCQ39739442-9D658ABD-3F63-443D-80E8-1C736881B880Q39852583-DEEA7696-63A3-4E10-B0B1-86B7C7D5882DQ40171494-48FB76D0-85FF-4E73-9E3D-7826CB423F23Q40253031-0FBEE770-3284-4F43-938A-13C7E3AD3A89Q40503493-006D4954-DC7F-4EC9-9540-FA888AA5F462Q41364307-D578245C-1D76-4A38-986F-B9CC75857C27Q42546927-D4731B9A-53B6-48EC-83DC-50D43F9E8E3BQ42555499-6D589BAC-10E4-4B7A-9C20-40A3937CB69FQ43598045-4ED2C824-93BC-44AD-8B42-66D3EAA348FCQ44061473-AE152E0D-9F50-4E22-BBB7-9812AF3F2F9BQ44391017-3C5AD15A-2B2C-488C-8B1A-94B21C8E092BQ44511468-61EAE642-9437-4401-9C51-B183572F9433Q46093785-67F4E84C-2C21-4496-A281-D94C5EFECF87Q47597174-D8C8554D-0298-46E8-BF18-C481433A41AFQ47866057-A5D90D13-52C7-42BA-9FD0-9C86C402BE97Q48960395-8C13747B-AB99-4996-A006-1C921D44D052
P2860
Increased norepinephrine levels and decreased dopamine-beta-hydroxylase activity in primary autism.
description
1977 nî lūn-bûn
@nan
1977年の論文
@ja
1977年学术文章
@wuu
1977年学术文章
@zh
1977年学术文章
@zh-cn
1977年学术文章
@zh-hans
1977年学术文章
@zh-my
1977年学术文章
@zh-sg
1977年學術文章
@yue
1977年學術文章
@zh-hant
name
Increased norepinephrine level ...... se activity in primary autism.
@en
Increased norepinephrine level ...... se activity in primary autism.
@nl
type
label
Increased norepinephrine level ...... se activity in primary autism.
@en
Increased norepinephrine level ...... se activity in primary autism.
@nl
prefLabel
Increased norepinephrine level ...... se activity in primary autism.
@en
Increased norepinephrine level ...... se activity in primary autism.
@nl
P2093
P921
P1433
P1476
Increased norepinephrine level ...... se activity in primary autism.
@en
P2093
P304
P356
10.1001/ARCHPSYC.1977.01770170063005
P407
P577
1977-05-01T00:00:00Z